 Jeremy Prager
Concepts (384)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trachea | 13 | 2022 | 233 | 3.050 |
Why?
| | Otolaryngology | 7 | 2022 | 71 | 2.110 |
Why?
| | Respiratory Tract Diseases | 4 | 2019 | 142 | 1.740 |
Why?
| | Tracheal Stenosis | 6 | 2023 | 24 | 1.740 |
Why?
| | Laryngoscopy | 7 | 2020 | 92 | 1.590 |
Why?
| | Tonsillectomy | 4 | 2021 | 72 | 1.590 |
Why?
| | Bronchoscopy | 12 | 2021 | 245 | 1.450 |
Why?
| | Tracheomalacia | 4 | 2022 | 19 | 1.290 |
Why?
| | Correspondence as Topic | 3 | 2012 | 15 | 1.190 |
Why?
| | Larynx | 3 | 2018 | 48 | 1.130 |
Why?
| | Laryngostenosis | 3 | 2023 | 20 | 1.080 |
Why?
| | Deglutition Disorders | 4 | 2023 | 119 | 1.060 |
Why?
| | Otitis Media | 7 | 2023 | 142 | 1.010 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2018 | 102 | 1.000 |
Why?
| | Airway Obstruction | 6 | 2021 | 168 | 0.900 |
Why?
| | Esophagoscopy | 4 | 2020 | 183 | 0.900 |
Why?
| | Operating Rooms | 2 | 2015 | 87 | 0.890 |
Why?
| | Efficiency, Organizational | 4 | 2019 | 126 | 0.880 |
Why?
| | Gastrointestinal Diseases | 3 | 2019 | 184 | 0.860 |
Why?
| | Child | 50 | 2023 | 18488 | 0.830 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 3 | 2021 | 33 | 0.800 |
Why?
| | Adenoidectomy | 4 | 2021 | 60 | 0.800 |
Why?
| | Otorhinolaryngologic Diseases | 2 | 2019 | 14 | 0.780 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 25 | 0.770 |
Why?
| | Respiratory Sounds | 2 | 2018 | 111 | 0.750 |
Why?
| | Abscess | 1 | 2020 | 72 | 0.700 |
Why?
| | Internship and Residency | 4 | 2020 | 951 | 0.700 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 136 | 0.690 |
Why?
| | Patient Care Team | 3 | 2019 | 521 | 0.690 |
Why?
| | Ancillary Services, Hospital | 1 | 2019 | 2 | 0.690 |
Why?
| | Hospitals, Pediatric | 6 | 2020 | 478 | 0.680 |
Why?
| | Digestive System Diseases | 1 | 2019 | 23 | 0.660 |
Why?
| | Craniocerebral Trauma | 1 | 2020 | 129 | 0.660 |
Why?
| | Helicobacter Infections | 1 | 2018 | 25 | 0.640 |
Why?
| | Helicobacter pylori | 1 | 2018 | 30 | 0.640 |
Why?
| | Intubation, Intratracheal | 3 | 2015 | 215 | 0.630 |
Why?
| | Tracheostomy | 2 | 2019 | 100 | 0.620 |
Why?
| | Tracheal Neoplasms | 1 | 2018 | 11 | 0.610 |
Why?
| | Eosinophilic Esophagitis | 3 | 2019 | 295 | 0.610 |
Why?
| | Humans | 78 | 2023 | 115587 | 0.590 |
Why?
| | Quality Improvement | 3 | 2016 | 958 | 0.580 |
Why?
| | Paraganglioma | 1 | 2018 | 47 | 0.570 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 231 | 0.540 |
Why?
| | Clinical Competence | 4 | 2020 | 912 | 0.530 |
Why?
| | Child, Preschool | 29 | 2023 | 9133 | 0.520 |
Why?
| | Gastroesophageal Reflux | 4 | 2023 | 235 | 0.520 |
Why?
| | Tracheoesophageal Fistula | 3 | 2022 | 31 | 0.510 |
Why?
| | Patient Satisfaction | 2 | 2019 | 585 | 0.510 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2015 | 25 | 0.510 |
Why?
| | Postoperative Complications | 6 | 2022 | 2161 | 0.500 |
Why?
| | Gastroenterology | 3 | 2023 | 158 | 0.500 |
Why?
| | Retrospective Studies | 23 | 2023 | 12608 | 0.500 |
Why?
| | Infant | 21 | 2022 | 7979 | 0.500 |
Why?
| | Phenol | 1 | 2014 | 18 | 0.480 |
Why?
| | Spinal Fractures | 1 | 2015 | 78 | 0.480 |
Why?
| | Drug Labeling | 1 | 2014 | 42 | 0.470 |
Why?
| | Burns, Chemical | 1 | 2014 | 25 | 0.470 |
Why?
| | Anti-Infective Agents, Local | 1 | 2014 | 39 | 0.470 |
Why?
| | Male | 41 | 2023 | 55949 | 0.460 |
Why?
| | Congenital Abnormalities | 1 | 2014 | 74 | 0.460 |
Why?
| | Thyroid Neoplasms | 3 | 2023 | 262 | 0.450 |
Why?
| | Medical Audit | 1 | 2014 | 75 | 0.450 |
Why?
| | Chromosome Disorders | 1 | 2013 | 34 | 0.450 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 225 | 0.430 |
Why?
| | Career Choice | 2 | 2011 | 183 | 0.430 |
Why?
| | Consensus | 6 | 2022 | 532 | 0.420 |
Why?
| | Sleep Apnea Syndromes | 1 | 2013 | 74 | 0.400 |
Why?
| | Abnormalities, Multiple | 1 | 2013 | 176 | 0.400 |
Why?
| | Student Dropouts | 1 | 2011 | 6 | 0.390 |
Why?
| | Female | 38 | 2023 | 59913 | 0.390 |
Why?
| | Writing | 1 | 2012 | 85 | 0.380 |
Why?
| | Job Description | 1 | 2010 | 10 | 0.370 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2012 | 154 | 0.370 |
Why?
| | Pediatrics | 4 | 2019 | 986 | 0.370 |
Why?
| | Pharyngeal Diseases | 1 | 2010 | 12 | 0.370 |
Why?
| | Deafness | 1 | 2012 | 78 | 0.370 |
Why?
| | Pulmonary Embolism | 1 | 2013 | 182 | 0.370 |
Why?
| | Education, Medical, Continuing | 1 | 2011 | 119 | 0.360 |
Why?
| | Cochlear Implantation | 1 | 2012 | 80 | 0.360 |
Why?
| | School Admission Criteria | 1 | 2010 | 20 | 0.360 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 528 | 0.360 |
Why?
| | Bronchiectasis | 3 | 2020 | 108 | 0.360 |
Why?
| | Fucosyltransferases | 2 | 2022 | 28 | 0.360 |
Why?
| | Personnel Selection | 1 | 2010 | 67 | 0.340 |
Why?
| | Tracheotomy | 4 | 2019 | 20 | 0.330 |
Why?
| | Anesthesia | 2 | 2023 | 119 | 0.330 |
Why?
| | Infant, Newborn | 8 | 2023 | 5077 | 0.330 |
Why?
| | Microbiota | 5 | 2023 | 652 | 0.330 |
Why?
| | Palatine Tonsil | 2 | 2021 | 32 | 0.330 |
Why?
| | Adolescent | 22 | 2022 | 17889 | 0.320 |
Why?
| | Thoracoscopy | 2 | 2019 | 53 | 0.320 |
Why?
| | Esophageal Atresia | 2 | 2020 | 25 | 0.310 |
Why?
| | Faculty, Medical | 1 | 2010 | 234 | 0.310 |
Why?
| | Hearing Loss, Conductive | 1 | 2007 | 22 | 0.300 |
Why?
| | Craniosynostoses | 1 | 2007 | 28 | 0.300 |
Why?
| | Down Syndrome | 2 | 2023 | 336 | 0.290 |
Why?
| | Delphi Technique | 7 | 2022 | 164 | 0.280 |
Why?
| | Program Development | 2 | 2019 | 350 | 0.270 |
Why?
| | Ear, Middle | 5 | 2023 | 89 | 0.270 |
Why?
| | Treatment Outcome | 8 | 2023 | 9159 | 0.270 |
Why?
| | Surgeons | 2 | 2020 | 238 | 0.270 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1405 | 0.250 |
Why?
| | Respiratory Tract Infections | 3 | 2021 | 323 | 0.250 |
Why?
| | Tracheobronchomalacia | 2 | 2022 | 14 | 0.250 |
Why?
| | Biopsy | 3 | 2019 | 1056 | 0.250 |
Why?
| | Sutures | 2 | 2021 | 60 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 2023 | 6 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia Type 2b | 1 | 2023 | 6 | 0.230 |
Why?
| | Membrane Proteins | 2 | 2021 | 1024 | 0.230 |
Why?
| | Multiple Endocrine Neoplasia Type 2a | 1 | 2023 | 8 | 0.220 |
Why?
| | Croup | 1 | 2023 | 22 | 0.220 |
Why?
| | Vocal Cord Dysfunction | 1 | 2022 | 6 | 0.210 |
Why?
| | Colorado | 5 | 2020 | 4113 | 0.210 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2022 | 4 | 0.200 |
Why?
| | Hypoparathyroidism | 1 | 2022 | 4 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2022 | 30 | 0.200 |
Why?
| | Graves Disease | 1 | 2022 | 32 | 0.200 |
Why?
| | Constriction, Pathologic | 4 | 2023 | 210 | 0.200 |
Why?
| | Laryngoscopes | 1 | 2022 | 38 | 0.200 |
Why?
| | Nasopharynx | 1 | 2022 | 63 | 0.200 |
Why?
| | Medicine | 1 | 2023 | 103 | 0.200 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Job Satisfaction | 1 | 2023 | 170 | 0.190 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 10 | 0.190 |
Why?
| | Nasal Obstruction | 1 | 2021 | 22 | 0.190 |
Why?
| | Nasal Septum | 1 | 2020 | 16 | 0.180 |
Why?
| | Follow-Up Studies | 7 | 2019 | 4440 | 0.180 |
Why?
| | Hematoma | 1 | 2020 | 50 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 32 | 0.180 |
Why?
| | Bevacizumab | 1 | 2021 | 118 | 0.180 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.180 |
Why?
| | Bone Marrow Transplantation | 4 | 1997 | 239 | 0.170 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2022 | 202 | 0.170 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 13 | 0.170 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 8 | 0.170 |
Why?
| | Tracheal Diseases | 1 | 2019 | 15 | 0.170 |
Why?
| | United States | 7 | 2019 | 12295 | 0.170 |
Why?
| | Cartilage | 1 | 2021 | 182 | 0.170 |
Why?
| | Arytenoid Cartilage | 1 | 2019 | 4 | 0.170 |
Why?
| | Papillomavirus Infections | 2 | 2021 | 258 | 0.170 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.170 |
Why?
| | Speech-Language Pathology | 1 | 2019 | 17 | 0.160 |
Why?
| | Angiogenesis Inhibitors | 1 | 2021 | 216 | 0.160 |
Why?
| | Laryngomalacia | 1 | 2018 | 5 | 0.160 |
Why?
| | Laryngoplasty | 1 | 2018 | 5 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 54 | 0.160 |
Why?
| | Airway Extubation | 1 | 2019 | 45 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2020 | 296 | 0.160 |
Why?
| | Pain, Postoperative | 1 | 2020 | 195 | 0.160 |
Why?
| | Models, Organizational | 1 | 2019 | 143 | 0.160 |
Why?
| | Virtual Reality | 1 | 2019 | 37 | 0.160 |
Why?
| | Young Adult | 8 | 2023 | 10470 | 0.160 |
Why?
| | Respiratory System | 1 | 2019 | 141 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 185 | 0.150 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2578 | 0.150 |
Why?
| | Child Behavior | 1 | 2020 | 218 | 0.150 |
Why?
| | Pulmonary Medicine | 1 | 2019 | 88 | 0.150 |
Why?
| | Esophageal Mucosa | 1 | 2018 | 17 | 0.150 |
Why?
| | Respiration Disorders | 1 | 2018 | 68 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 230 | 0.150 |
Why?
| | Burnout, Professional | 1 | 2023 | 322 | 0.150 |
Why?
| | Proton Pump Inhibitors | 1 | 2018 | 96 | 0.150 |
Why?
| | Carcinoma, Medullary | 1 | 2017 | 13 | 0.150 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 330 | 0.150 |
Why?
| | Reoperation | 2 | 2018 | 525 | 0.150 |
Why?
| | Gastrostomy | 1 | 2018 | 89 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 254 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 601 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 548 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 732 | 0.130 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 8 | 0.130 |
Why?
| | Androstanols | 1 | 2015 | 7 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2125 | 0.130 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 489 | 0.130 |
Why?
| | Anesthetics, Intravenous | 1 | 2015 | 27 | 0.130 |
Why?
| | Midazolam | 1 | 2015 | 43 | 0.130 |
Why?
| | Prognosis | 3 | 2018 | 3339 | 0.130 |
Why?
| | Clinical Audit | 1 | 2015 | 11 | 0.130 |
Why?
| | Mouth | 1 | 2015 | 67 | 0.130 |
Why?
| | Time and Motion Studies | 1 | 2015 | 21 | 0.130 |
Why?
| | Fentanyl | 1 | 2015 | 66 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 3 | 2020 | 2392 | 0.120 |
Why?
| | Survival Rate | 2 | 2018 | 1650 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 344 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.120 |
Why?
| | Program Evaluation | 1 | 2019 | 836 | 0.120 |
Why?
| | Respiratory Aspiration | 1 | 2014 | 31 | 0.120 |
Why?
| | Administration, Intranasal | 1 | 2014 | 75 | 0.120 |
Why?
| | Quality of Health Care | 1 | 2019 | 576 | 0.120 |
Why?
| | Pedigree | 3 | 2020 | 467 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2018 | 478 | 0.120 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 6 | 0.120 |
Why?
| | Iatrogenic Disease | 1 | 2014 | 51 | 0.120 |
Why?
| | Anesthetics, Local | 1 | 2014 | 84 | 0.110 |
Why?
| | Appointments and Schedules | 1 | 2014 | 74 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 877 | 0.110 |
Why?
| | Chromosome Deletion | 1 | 2013 | 95 | 0.110 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 68 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 123 | 0.110 |
Why?
| | Rhinitis | 1 | 2014 | 128 | 0.110 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 4665 | 0.110 |
Why?
| | Radiography | 1 | 2015 | 826 | 0.110 |
Why?
| | Pharyngitis | 1 | 2013 | 23 | 0.110 |
Why?
| | Tetanus Antitoxin | 1 | 1992 | 3 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1536 | 0.100 |
Why?
| | Graft Rejection | 1 | 2016 | 533 | 0.100 |
Why?
| | Tetanus Toxoid | 1 | 1992 | 37 | 0.100 |
Why?
| | Sinusitis | 1 | 2014 | 175 | 0.100 |
Why?
| | Mutation | 2 | 2021 | 3364 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2015 | 414 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 286 | 0.100 |
Why?
| | Immunization, Secondary | 1 | 1992 | 82 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1334 | 0.100 |
Why?
| | Patient Safety | 1 | 2015 | 276 | 0.100 |
Why?
| | Time Factors | 3 | 2019 | 6165 | 0.100 |
Why?
| | Cytosine | 1 | 2011 | 44 | 0.090 |
Why?
| | Patient Readmission | 1 | 2016 | 609 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2015 | 646 | 0.090 |
Why?
| | Off-Label Use | 1 | 2011 | 52 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2800 | 0.090 |
Why?
| | Ear Ossicles | 1 | 2010 | 15 | 0.090 |
Why?
| | Organophosphonates | 1 | 2011 | 91 | 0.090 |
Why?
| | Asthma | 1 | 2023 | 2066 | 0.090 |
Why?
| | Airway Management | 1 | 2011 | 60 | 0.090 |
Why?
| | Prospective Studies | 3 | 2021 | 6264 | 0.090 |
Why?
| | Teratoma | 1 | 2011 | 92 | 0.090 |
Why?
| | Professional Competence | 1 | 2010 | 86 | 0.090 |
Why?
| | Hospitalization | 1 | 2018 | 1765 | 0.090 |
Why?
| | Thyroidectomy | 2 | 2022 | 52 | 0.090 |
Why?
| | Disclosure | 1 | 2010 | 102 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2016 | 805 | 0.080 |
Why?
| | Communication | 1 | 2015 | 750 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3069 | 0.080 |
Why?
| | Patient Selection | 1 | 2012 | 654 | 0.080 |
Why?
| | Prevalence | 2 | 2020 | 2264 | 0.080 |
Why?
| | Middle Ear Ventilation | 1 | 2007 | 10 | 0.080 |
Why?
| | Audiometry | 1 | 2007 | 30 | 0.080 |
Why?
| | Esophagus | 2 | 2020 | 226 | 0.070 |
Why?
| | Mice | 5 | 2022 | 15052 | 0.070 |
Why?
| | Risk Factors | 3 | 2019 | 8697 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2011 | 651 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 425 | 0.070 |
Why?
| | Pilot Projects | 1 | 2010 | 1377 | 0.070 |
Why?
| | Hematologic Diseases | 1 | 1986 | 57 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 1986 | 79 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1180 | 0.060 |
Why?
| | Cadaver | 2 | 2019 | 316 | 0.060 |
Why?
| | Transplantation, Homologous | 4 | 2011 | 397 | 0.060 |
Why?
| | Hyperplasia | 1 | 2023 | 166 | 0.050 |
Why?
| | Breathing Exercises | 1 | 2022 | 19 | 0.050 |
Why?
| | Cough | 1 | 2023 | 107 | 0.050 |
Why?
| | Vocal Cords | 1 | 2022 | 26 | 0.050 |
Why?
| | Biofeedback, Psychology | 1 | 2022 | 25 | 0.050 |
Why?
| | Animals | 5 | 2022 | 32102 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 50 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 334 | 0.050 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 1992 | 538 | 0.050 |
Why?
| | Esophagoscopes | 1 | 2020 | 4 | 0.050 |
Why?
| | Deglutition | 1 | 2021 | 58 | 0.050 |
Why?
| | Nasal Cavity | 1 | 2021 | 47 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 4773 | 0.050 |
Why?
| | Perioperative Period | 1 | 2020 | 49 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 250 | 0.040 |
Why?
| | Internationality | 1 | 2021 | 145 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 1893 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 509 | 0.040 |
Why?
| | Social Support | 1 | 2023 | 537 | 0.040 |
Why?
| | Lung | 2 | 2023 | 3672 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Laryngeal Mucosa | 1 | 2019 | 7 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2020 | 99 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 72 | 0.040 |
Why?
| | Finland | 1 | 2019 | 70 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 189 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 255 | 0.040 |
Why?
| | California | 1 | 2020 | 367 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2020 | 234 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| | Nerve Fibers | 1 | 2019 | 87 | 0.040 |
Why?
| | Infant, Premature | 1 | 2022 | 477 | 0.040 |
Why?
| | Emotions | 1 | 2023 | 477 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 175 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 99 | 0.040 |
Why?
| | Device Removal | 1 | 2019 | 128 | 0.040 |
Why?
| | Anesthetics | 1 | 2018 | 57 | 0.040 |
Why?
| | Interdisciplinary Research | 1 | 2018 | 25 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 109 | 0.040 |
Why?
| | Exome | 1 | 2018 | 202 | 0.040 |
Why?
| | Transplantation, Autologous | 3 | 1992 | 173 | 0.040 |
Why?
| | Chickenpox Vaccine | 1 | 1997 | 69 | 0.040 |
Why?
| | Perioperative Care | 1 | 2018 | 126 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2017 | 105 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 390 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2018 | 186 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 211 | 0.030 |
Why?
| | Survival Analysis | 2 | 2017 | 1219 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 741 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 952 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 602 | 0.030 |
Why?
| | Taste Buds | 1 | 2019 | 209 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1473 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 445 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 477 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 736 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 2907 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 645 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 621 | 0.030 |
Why?
| | Hypertrophy | 1 | 2015 | 110 | 0.030 |
Why?
| | Tongue | 1 | 2015 | 67 | 0.030 |
Why?
| | Adolescent Behavior | 1 | 2020 | 480 | 0.030 |
Why?
| | Long-Term Care | 1 | 2015 | 76 | 0.030 |
Why?
| | Health Services Research | 1 | 2018 | 377 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 563 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 519 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1642 | 0.030 |
Why?
| | Adult | 5 | 2023 | 30718 | 0.030 |
Why?
| | Registries | 1 | 2022 | 1770 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1178 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2017 | 340 | 0.030 |
Why?
| | Fetal Therapies | 1 | 2013 | 30 | 0.030 |
Why?
| | Thoracotomy | 1 | 2013 | 67 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2416 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1918 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2651 | 0.030 |
Why?
| | Neoplasms | 1 | 1986 | 2118 | 0.030 |
Why?
| | Tetanus | 1 | 1992 | 25 | 0.030 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 194 | 0.030 |
Why?
| | Endoscopy | 1 | 2014 | 247 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2013 | 235 | 0.030 |
Why?
| | Anemia, Aplastic | 1 | 1992 | 30 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 4944 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2011 | 32 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2335 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2499 | 0.020 |
Why?
| | Malleus | 1 | 2010 | 1 | 0.020 |
Why?
| | Incus | 1 | 2010 | 8 | 0.020 |
Why?
| | Stapes | 1 | 2010 | 31 | 0.020 |
Why?
| | Temporal Bone | 1 | 2010 | 44 | 0.020 |
Why?
| | Graft vs Host Disease | 1 | 1992 | 212 | 0.020 |
Why?
| | Aerosols | 1 | 2011 | 150 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2353 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 644 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1992 | 269 | 0.020 |
Why?
| | Graft Survival | 1 | 2011 | 480 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1598 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1044 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1440 | 0.020 |
Why?
| | Stents | 1 | 2011 | 475 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 495 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 641 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4541 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1856 | 0.020 |
Why?
| | Heart Atria | 1 | 1986 | 110 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1484 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 4435 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1991 | 1361 | 0.010 |
Why?
| | Pregnancy | 1 | 2013 | 5548 | 0.010 |
Why?
| | Pancreatic Function Tests | 1 | 1981 | 3 | 0.010 |
Why?
| | Exocrine Pancreatic Insufficiency | 1 | 1981 | 17 | 0.010 |
Why?
| | Middle Aged | 3 | 2019 | 26999 | 0.010 |
Why?
| | Somatostatin | 1 | 1980 | 53 | 0.010 |
Why?
| | Dietary Fats | 1 | 1980 | 289 | 0.010 |
Why?
| | Triglycerides | 1 | 1980 | 473 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 1997 | 73 | 0.010 |
Why?
| | Chickenpox | 1 | 1997 | 94 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1997 | 332 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 1997 | 527 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1997 | 781 | 0.010 |
Why?
| | Herpes Zoster | 1 | 1997 | 333 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 1870 | 0.010 |
Why?
| | Bone Marrow Purging | 1 | 1991 | 3 | 0.010 |
Why?
| | Daunorubicin | 1 | 1991 | 24 | 0.010 |
Why?
| | Thioguanine | 1 | 1991 | 19 | 0.010 |
Why?
| | Cytarabine | 1 | 1991 | 52 | 0.010 |
Why?
| | Remission Induction | 1 | 1992 | 240 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1992 | 294 | 0.010 |
Why?
| | Vaccination | 1 | 1997 | 1209 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1991 | 1127 | 0.000 |
Why?
| | Fluoresceins | 1 | 1981 | 46 | 0.000 |
Why?
| | Lipase | 1 | 1980 | 66 | 0.000 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1980 | 151 | 0.000 |
Why?
| | Cholesterol | 1 | 1980 | 369 | 0.000 |
Why?
| | Blood Glucose | 1 | 1980 | 1824 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2082 | 0.000 |
Why?
|
|
Prager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|